Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: Final analysis of a long-term follow-up study up to 9.4 years post-vaccination

HPV-023 (NCT00518336; ClinicalTrial.gov) is a long-term follow-up of an initial double-blind, randomized (1:1), placebo-controlled study (HPV-001, NCT00689741) evaluating the efficacy against human papillomavirus (HPV)-16/18 infection and associated cyto-histopathological abnormalities, persistence...

Descripción completa

Detalles Bibliográficos
Autores principales: Naud, Paulo S, Roteli-Martins, Cecilia M, De Carvalho, Newton S, Teixeira, Julio C, de Borba, Paola C, Sanchez, Nervo, Zahaf, Toufik, Catteau, Gregory, Geeraerts, Brecht, Descamps, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896780/
https://www.ncbi.nlm.nih.gov/pubmed/25424918
http://dx.doi.org/10.4161/hv.29532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896780/
https://www.ncbi.nlm.nih.gov/pubmed/25424918
http://dx.doi.org/10.4161/hv.29532

Ejemplares similares